Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
Search by expertise, name or affiliation
The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment
Tao Wang
,
Kewei Chen
, Huafang Li
, Shuhui Dong
, Ning Su
, Yuanyuan Liu
, Yan Cheng
, Jing Dai
, Cece Yang
, Shifu Xiao
Research output
:
Contribution to journal
›
Article
›
peer-review
45
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gene Expression
100%
Clinical Diagnosis
100%
RNA Genes
100%
Amnestic Mild Cognitive Impairment (aMCI)
100%
β-site APP-cleaving Enzyme 1 (BACE1)
100%
Messenger RNA (mRNA)
100%
Healthy Controls
85%
Alzheimer's Disease
57%
Related Disorders
14%
Quantitative PCR
14%
Diagnostic Ability
14%
Classification Accuracy
14%
Diagnostic Criteria
14%
Cerebrospinal Fluid
14%
Linear Discriminant Analysis
14%
Pearson Correlation
14%
Cognitive-communication Disorder
14%
Neurologic Disorders
14%
R-value
14%
DSM-IV
14%
High Capability
14%
Overall Classification Accuracy
14%
Neuroscience
Gene Expression
100%
Mild Cognitive Impairment
100%
RNA Gene
100%
Blood Plasma
100%
Messenger RNA
100%
Alzheimer's Disease
57%
Real-Time Polymerase Chain Reaction
14%
Communication Disorder
14%
Cerebrovascular Accident
14%